{"id":"W3030792017","doi":"10.1200/jco.2020.38.15_suppl.9065","title":"Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Olaparib; Medicine; PARP inhibitor; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Adverse effect; Phases of clinical research; Chemotherapy; Gastroenterology; Clinical trial; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002643869,0.001169026,0.001785949,0.0004176457,0.0005426557,0.0010222,0.0007622725,0.000948516,0.002035778],"category_scores_gemma":[0.001463867,0.0004212694,0.001149312,0.0006364347,0.0005361435,0.0005531344,0.0004072166,0.001645541,0.0006752367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008055308,"about_ca_system_score_gemma":0.001293974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001353025,"about_ca_topic_score_gemma":0.003533204,"domain_scores_codex":[0.9991454,0.0005005139,0.00005726937,0.0001057716,0.0001073226,0.00008376074],"domain_scores_gemma":[0.9986128,0.0002567646,0.0003065222,0.0001488289,0.0001174792,0.0005575431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5965931,0.03728355,0.1993884,0.001038087,0.006539919,0.001117336,0.0005218881,0.004053132,0.06802192,0.000174073,0.008714708,0.07655375],"study_design_scores_gemma":[0.3249091,0.2530813,0.3993149,0.00007822149,0.003578121,0.001777321,0.0001394219,0.002221808,0.00715801,0.0001663594,0.007499124,0.00007636681],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932708,0.001171604,0.0002576603,0.0002010363,0.00001965061,0.00105467,0.002687329,0.00004662248,0.001290623],"genre_scores_gemma":[0.984814,0.0009809814,0.001014158,0.0004886458,0.0001038662,0.001252539,0.01036868,0.00003131653,0.0009458023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002643869,"threshold_uncertainty_score":0.0139823,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1671966402971293,"score_gpt":0.5222723428559617,"score_spread":0.3550757025588324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}